¼¼°èÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå º¸°í¼­(2025³â)
Heart Closure Devices Global Market Report 2025
»óǰÄÚµå : 1717030
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÀå Æó¼â ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â11.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 48¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¼±Ãµ¼º ½ÉÀ庴 ¹ß»ý·ü Áõ°¡, MRI ½Ã¼ú äÅà Áõ°¡, ½ÉÀ帶ºñ Áõ°¡, ½É¹æ¼¼µ¿ ¹ß»ý·ü Áõ°¡, ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ´Ù±â´É ÀåÄ¡ÀÇ ÅëÇÕ, ±â¼ú ¹ßÀü, Àç·á ¹× µðÀÚÀÎ Çõ½Å, À̹Ì¡ ±â¼ú µµÀÔ, »ýü Èí¼ö¼º Àç·áÀÇ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü Áúȯ(CVDs)ÀÇ À¯º´·ü Áõ°¡´Â ½ÉÀå Æó¼â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CVD Áõ°¡´Â °í·ÉÈ­, °Ç°­¿¡ ÇØ·Î¿î »ýȰ½À°ü ¼±ÅÃ, À¯ÀüÀû ¼ÒÀÎ, °íÇ÷¾Ð, ´ç´¢º´, ºñ¸¸°ú °°Àº À§Çè¿äÀÎÀÇ ³ôÀº À¯º´·ü µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ½ÉÀå Æó¼â ±â±â´Â ÃÖ¼ÒÇÑÀÇ Ä§½ÀÀ¸·Î ½ÉÀåÀÇ ºñÁ¤»óÀûÀÎ °³±¸ºÎ¸¦ ´Ý¾Æ Ç÷·ù¸¦ °³¼±Çϰí Ãß°¡ÀûÀÎ °Ç°­ ¹®Á¦¸¦ ¿¹¹æÇÔÀ¸·Î½á ¼±Ãµ¼º ½ÉÀå ÁúȯÀ¸·Î ÀÎÇÑ ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 5¿ù ½Ì°¡Æ÷¸£ ½ÉÀå Àç´ÜÀÇ º¸°í¿¡ µû¸£¸é 2023³â ½ÉÇ÷°ü°è ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â 2,6,885¸íÀ̸ç, ÇãÇ÷¼º ½ÉÀåÁúȯÀ¸·Î¸¸ 5,302¸íÀÌ »ç¸ÁÇÏ¿© Àü³â ´ëºñ ¼ÒÆø Áõ°¡ÇÏ¿´½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡°¡ ½ÉÀåÆó¼âÀåÄ¡ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÉÀå Æó¼â ±â±â ½ÃÀåÀÇ ±â¾÷µéÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ½Ã¼ú Áß ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ ³­¿ø°ø °³Á¸Áõ(PFO) Æó¼â ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, PFO Æó¼â ½Ã½ºÅÛÀº ¿ì½É¹æ°ú ÁÂ½É¹æ »çÀÌ¿¡ ÀÖ´Â Áö¼ÓÀûÀÎ ±¸¸ÛÀ» ¸·µµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, Abbott Laboratories´Â 2022³â 9¿ù PFO ȯÀÚ, ƯÈ÷ ³úÁ¹ÁßÀ» °æÇèÇÑ È¯ÀÚµéÀ» À§ÇÑ Amplatzer Talisman PFO Æó»ö ½Ã½ºÅÛÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ½Ã¼ú °£¼ÒÈ­¸¦ À§ÇÑ »çÀü ÀåÂøµÈ ¿ÀŬ·ç´õ, ÀûÀÀ¼ºÀ» ³ôÀ̱â À§ÇÑ ´Ù¿ëµµ 30mm Å©±â, PFOÀÇ È¿°úÀûÀÎ Æó¼â¸¦ º¸ÀåÇϰí ÇâÈÄ ³úÁ¹Áß À§ÇèÀ» ÁÙÀ̱â À§ÇÑ ¿ÏÀü ÀçÆ÷ȹÀÌ °¡´ÉÇÑ µðÀÚÀÎÀ» Ư¡À¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Heart closure devices are sophisticated medical instruments designed to close holes or openings in the heart, often resulting from congenital defects or surgical procedures. These devices are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart issues. Typically, they are delivered through catheter-based procedures, providing a safer alternative to open-heart surgery.

The main types of heart closure devices include atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and others. ASD closure devices are implants used to seal abnormal openings in the septum between the heart's upper chambers and are usually deployed through minimally invasive catheter-based procedures. These devices are commonly made from materials such as nitinol, stainless steel, and other substances. Delivery methods include both transcatheter and surgical approaches, and these devices are utilized in various healthcare settings such as hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories.

The heart closure devices market research report is one of a series of new reports from The Business Research Company that provides heart closure devices market statistics, including the heart closure devices industry global market size, regional shares, competitors with the heart closure devices market share, detailed heart closure devices market segments, market trends, and opportunities, and any further data you may need to thrive in the heart closure devices industry. This heart closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heart closure devices market size has grown rapidly in recent years. It will grow from $2.77 billion in 2024 to $3.10 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth during the historical period can be attributed to factors such as greater awareness among healthcare providers, an increase in device approvals by regulatory authorities, favorable reimbursement policies, a rise in cardiovascular diseases, and a growing geriatric population.

The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $4.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The projected growth in the forecast period is driven by factors including the rising incidence of congenital heart defects, increased adoption of MRI procedures, a growing number of heart strokes, higher incidence of atrial fibrillation, and an increasing preference for minimally invasive procedures. Key trends anticipated during this period include the integration of multi-functional devices, technological advancements, innovations in materials and design, the incorporation of imaging technologies, and the development of bioresorbable materials.

The increasing incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the heart closure devices market. The rise in CVDs is attributed to factors such as aging, unhealthy lifestyle choices, genetic predisposition, and a higher prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices play a crucial role in minimizing complications caused by congenital heart defects by closing abnormal openings in the heart with minimal invasiveness, improving blood flow, and preventing further health issues. For instance, in May 2024, the Singapore Heart Foundation reported that cardiovascular diseases accounted for 26,885 deaths in 2023, with ischemic heart disease alone causing 5,302 deaths, showing a slight increase from the previous year. This growing incidence of cardiovascular diseases is driving the demand for heart closure devices.

Companies in the heart closure devices market are focusing on innovative solutions, such as patent foramen ovale (PFO) occlusion systems, to improve patient outcomes and reduce complications during procedures. PFO occlusion systems are designed to close a persistent hole between the right and left atria, which should have closed after birth but remains open in some individuals. For example, in September 2022, Abbott Laboratories launched the Amplatzer Talisman PFO Occlusion System, specifically for individuals with PFO, especially those who have experienced a stroke. The system features a pre-attached occluder for simplified procedures, a versatile 30mm size for better adaptability, and a fully recapturable design to ensure effective closure of the PFO and reduce the risk of future strokes.

In November 2023, Johnson & Johnson MedTech, a US-based medical device company, acquired Laminar Inc. for $400 million. This acquisition enhances Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatment, strengthens its market presence in left atrial appendage elimination devices, and enables innovation in stroke prevention solutions for patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based manufacturer specializing in heart closure devices.

Major players in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., and MicroPort Scientific Corporation.

North America was the largest region in the heart closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart closure devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heart closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Closure Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for heart closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heart closure devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Heart Closure Devices Market Characteristics

3. Heart Closure Devices Market Trends And Strategies

4. Heart Closure Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Heart Closure Devices Growth Analysis And Strategic Analysis Framework

6. Heart Closure Devices Market Segmentation

7. Heart Closure Devices Market Regional And Country Analysis

8. Asia-Pacific Heart Closure Devices Market

9. China Heart Closure Devices Market

10. India Heart Closure Devices Market

11. Japan Heart Closure Devices Market

12. Australia Heart Closure Devices Market

13. Indonesia Heart Closure Devices Market

14. South Korea Heart Closure Devices Market

15. Western Europe Heart Closure Devices Market

16. UK Heart Closure Devices Market

17. Germany Heart Closure Devices Market

18. France Heart Closure Devices Market

19. Italy Heart Closure Devices Market

20. Spain Heart Closure Devices Market

21. Eastern Europe Heart Closure Devices Market

22. Russia Heart Closure Devices Market

23. North America Heart Closure Devices Market

24. USA Heart Closure Devices Market

25. Canada Heart Closure Devices Market

26. South America Heart Closure Devices Market

27. Brazil Heart Closure Devices Market

28. Middle East Heart Closure Devices Market

29. Africa Heart Closure Devices Market

30. Heart Closure Devices Market Competitive Landscape And Company Profiles

31. Heart Closure Devices Market Other Major And Innovative Companies

32. Global Heart Closure Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heart Closure Devices Market

34. Recent Developments In The Heart Closure Devices Market

35. Heart Closure Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â